CSAN(CSAN)
CSAN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $14.92B | $15.13B | $15.88B | $8.37B | $8.72B |
| Low | $13.35B | $14.36B | $14.65B | $7.72B | $8.05B |
| High | $16.11B | $16.48B | $17.22B | $9.08B | $9.46B |
| EBITDA Avg | $4.53B | $4.59B | $4.82B | $2.54B | $2.65B |
| Low | $4.05B | $4.35B | $4.44B | $2.34B | $2.44B |
| High | $4.88B | $5.00B | $5.22B | $2.75B | $2.87B |
| EBIT Avg | $3.25B | $3.29B | $3.46B | $1.82B | $1.90B |
| Low | $2.91B | $3.12B | $3.19B | $1.68B | $1.75B |
| High | $3.50B | $3.59B | $3.75B | $1.98B | $2.06B |
| Net Income Avg | $-91M | $466M | $1.04B | $1.21B | — |
| Low | $-101M | $419M | $933M | $1.08B | — |
| High | $-82M | $517M | $1.15B | $1.34B | — |
| EPS Avg | $-0.07 | $0.37 | $0.83 | $0.97 | — |
| Low | $-0.08 | $0.34 | $0.75 | $0.87 | — |
| High | $-0.07 | $0.41 | $0.92 | $1.07 | — |
| Analysts (Rev / EPS) | 4 / 1 | 4 / 1 | 2 / 1 | 3 / 1 | 3 / — |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $8.88B | $8.67B |
| Low | $8.88B | $8.67B |
| High | $8.88B | $8.67B |
| EBITDA Avg | $2.69B | $2.63B |
| Low | $2.69B | $2.63B |
| High | $2.69B | $2.63B |
| EBIT Avg | $1.93B | $1.89B |
| Low | $1.93B | $1.89B |
| High | $1.93B | $1.89B |
| Net Income Avg | $266M | $47M |
| Low | $266M | $47M |
| High | $266M | $47M |
| EPS Avg | $0.14 | $0.02 |
| Low | $0.14 | $0.02 |
| High | $0.14 | $0.02 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |